The Leadership Team at Jubilant Therapeutics is responsible for guiding the strategic direction of the company, ensuring financial sustainability, and fostering a culture of innovation. Comprising the President & CEO and VP & CFO, the team collaborates to prioritize patient-centric initiatives, drive research and development of small molecule modulators, and navigate the complexities of the biopharmaceutical landscape to address unmet medical needs in oncology and autoimmune diseases.